Clinical trial
Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)
NCT00135707 · The George Washington University Biostatistics Center, Other · Completed
Key facts
| NCT number | NCT00135707 |
|---|---|
| Title | Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS) |
| Official title | A Randomized Clinical Trial of Antioxidants to Prevent Preeclampsia and An Observational Cohort Study to Predict Preeclampsia |
| Acronym | CAPPS |
| Lead sponsor | The George Washington University Biostatistics Center, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Preeclampsia |
| Intervention type | Drug |
| Interventions | Dietary Supplement/Vitamins, Placebo for Vitamin C and Vitamin E |
| Enrollment | 10,154 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Aug 26, 2005 |
| Last update posted | Feb 21, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: